$3.71
0.02[0.54%]
At close: Apr 26
$3.71
0[0.00%]
After Hours: 4:20PM EDT
MaxCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of MaxCyte using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | MXCT | Q1 | -$0.11 | -$0.13 | — | — | $8.58M | $7.48M | — | — | Get Alert |
03/12/2024 | PM | MXCT | Q4 | -$0.05 | -$0.07 | -$0.05 | 28.57% | $12.42M | $13.09M | $15.67M | 19.68% | Get Alert |
11/08/2023 | PM | MXCT | Q3 | -$0.06 | -$0.10 | -$0.11 | -10.00% | $10.64M | $9.77M | $8.01M | -18.07% | Get Alert |
08/09/2023 | PM | MXCT | Q2 | -$0.08 | -$0.10 | -$0.10 | 0.00% | $9.61M | $10.80M | $9.04M | -16.27% | Get Alert |
05/10/2023 | PM | MXCT | Q1 | -$0.04 | -$0.11 | -$0.11 | 0.00% | $11.59M | $8.32M | $8.58M | 3.08% | Get Alert |
03/15/2023 | PM | MXCT | Q4 | -$0.05 | -$0.07 | -$0.05 | 28.57% | $10.15M | $12.90M | $12.42M | -3.69% | Get Alert |
11/09/2022 | PM | MXCT | Q3 | -$0.03 | -$0.09 | -$0.06 | 33.33% | $10.14M | $10.43M | $10.64M | 2.04% | Get Alert |
08/10/2022 | PM | MXCT | Q2 | -$0.05 | -$0.08 | -$0.08 | 0.00% | $7.11M | $9.22M | $9.61M | 4.21% | Get Alert |
05/09/2022 | PM | MXCT | Q1 | -$0.09 | -$0.07 | -$0.04 | 42.86% | $6.50M | $8.46M | $11.59M | 36.96% | Get Alert |
03/22/2022 | PM | MXCT | Q4 | -$0.03 | -$0.05 | -$0.05 | 0.00% | $8.51M | $9.45M | $10.15M | 7.43% | Get Alert |
11/10/2021 | PM | MXCT | Q3 | -$0.04 | -$0.05 | -$0.03 | 40.00% | — | $7.37M | $10.14M | 37.57% | Get Alert |
09/13/2021 | PM | MXCT | Q2 | -$0.05 | -$0.05 | -$0.05 | 0.00% | $5.20M | $5.95M | $7.11M | 19.46% | Get Alert |
MaxCyte (MXCT) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
The Actual EPS was $-0.05, which beat the estimate of $-0.07.
The Actual Revenue was $15.7M, which beat the estimate of $13.1M.
Browse earnings estimates, EPS, and revenue on all stocks.